Related Experiment Video
Updated: Jul 7, 2026

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
Published on: August 17, 2022
Monosomy 18p
1Cytogénétique AP-HP et Inserm U781, Université Paris Descartes, Hôpital Necker-Enfants Malades, 75015 Paris, France. turleau@necker.fr
Insights
Monosomy 18p is a chromosomal disorder affecting chromosome 18, characterized by mild features like short stature and intellectual deficiency. Genetic testing confirms diagnosis, with recurrence risks varying based on inheritance patterns.
Area of Science:
- Genetics
- Clinical Genetics
- Human Genetics
Background:
- Monosomy 18p is a chromosomal disorder caused by the deletion of part or all of the short arm of chromosome 18.
- It affects approximately 1 in 50,000 live births.
- Clinical manifestations are typically mild and non-specific, though a subset presents with severe malformations.
Purpose of the Study:
- To describe the clinical features, genetic causes, diagnostic methods, and recurrence risks associated with Monosomy 18p.
- To highlight the importance of cytogenetic analysis for accurate diagnosis and genetic counseling.
Main Methods:
- Review of clinical and cytogenetic data from patients with Monosomy 18p.
- Cytogenetic analysis (karyotyping, FISH, chromosomal microarray) for diagnosis.
- Prenatal diagnosis via amniocentesis or chorionic villus sampling.
Main Results:
- Common features include short stature, round face, palpebral ptosis, large ears, and mild to moderate intellectual deficiency.
- Genetic causes include terminal deletions, translocations, inversions, and ring chromosome 18.
- Recurrence risk is low for de novo events but significant with parental rearrangements.
Conclusions:
- Monosomy 18p diagnosis relies on cytogenetic analysis.
- Early intervention with speech therapy and educational programs can improve outcomes.
- Life expectancy is generally not significantly reduced, except in cases with severe brain malformations.
Abstract:
Monosomy 18p refers to a chromosomal disorder resulting from the deletion of all or part of the short arm of chromosome 18. The incidence is estimated to be about 1:50,000 live-born infants. In the commonest form of the disorder, the dysmorphic syndrome is very moderate and non-specific. The main clinical features are short stature, round face with short philtrum, palpebral ptosis and large ears with detached pinnae. Intellectual deficiency is mild to moderate. A small subset of patients, about 10-15 percent of cases, present with severe brain/facial malformations evocative of holoprosencephaly spectrum disorders. In two-thirds of the cases, the 18p- syndrome is due to a mere terminal deletion occurring de novo, in one-third the following are possible: a de novo translocation with loss of 18p, malsegregation of a parental translocation or inversion, or a ring chr18. Parental transmission of the 18p- syndrome has been reported. Cytogenetic analysis is necessary to make a definite diagnosis. Recurrence risk for siblings is low in de novo deletions and translocations, but is significant if a parental rearrangement is present. Deletion 18p can be detected prenatally by amniocentesis or chorionic villus sampling and cytogenetic testing. Differential diagnosis may include a wide number of syndromes with short stature and mild intellectual deficiency. In young children, deletion 18p syndrome may be vaguely evocative of either Turner syndrome or trisomy 21. No specific treatment exists but speech therapy and early educational programs may help to improve the performances of the children. Except for the patients with severe brain malformations, the life expectancy does not seem significantly reduced.
Related Concept Videos
Meiosis I
Nondisjunction
Nondisjunction
Nondisjunction
Karyotyping
Karyotyping

